gemcitabine has been researched along with betulin in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 2 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chen, B; Miao, Z; Wang, C; Wang, Y; Wu, Y; Yao, J; Zhang, Y; Zhu, Y | 1 |
| Miao, Z; Wang, C; Wang, Y; Wu, Y; Ye, S; Zhang, H; Zhang, Y; Zhu, Y | 1 |
2 other study(ies) available for gemcitabine and betulin
| Article | Year |
|---|---|
Discovery of natural product ellagic acid as a potent CD73 and CD39 dual inhibitor.
Topics: 5'-Nucleotidase; Antineoplastic Agents; Apyrase; Biological Products; Cell Line, Tumor; Cell Proliferation; Cell Survival; Dose-Response Relationship, Drug; Drug Discovery; Drug Screening Assays, Antitumor; Ellagic Acid; Enzyme Inhibitors; GPI-Linked Proteins; Humans; Molecular Structure; Structure-Activity Relationship | 2021 |
Discovery and optimization of betulinic acid derivatives as novel potent CD73 inhibitors.
Topics: 5'-Nucleotidase; Adenosine; Betulinic Acid; Humans; Immunotherapy; Neoplasms; Pentacyclic Triterpenes | 2022 |